Document is current
Any future updates will be listed below
-
Authors
Bellato, Alessio
Perna, John https://orcid.org/0000-0003-2588-3244
Ganapathy, Preethi S. https://orcid.org/0000-0001-5736-7485
Solmi, Marco https://orcid.org/0000-0003-4877-7233
Zampieri, Andrea
Cortese, Samuele
Faraone, Stephen V. https://orcid.org/0000-0002-9217-3982
- License Information
-
More Information
Article History
Received: 22 February 2022
Revised: 23 June 2022
Accepted: 1 July 2022
First Online: 5 August 2022
Competing interests
: In the past year, SVF received income, potential income, travel expenses continuing education support and/or research support from Aardvark, Rhodes, OnDosis, Tris, Otsuka, Arbor, Ironshore, KemPharm/Corium, Akili, Supernus, Takeda, Atentiv, Noven and Genomind. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. He also receives royalties from books published by Guilford Press: <i>Straight Talk about Your Child’s Mental Health</i>, Oxford University Press: <i>Schizophrenia: The Facts</i> and Elsevier: ADHD: <i>Non-Pharmacologic Interventions</i>. He is Program Director of . MS received fees from Angelini and Lundbeck. All other authors declare no Competing interests.
